Designing an Efficient Biocatalyst for the Phosphoribosylation of Antiviral Pyrazine-2-carboxamide Derivatives
EA Zayats, IV Fateev, YA Abramchik… - ACS …, 2024 - ACS Publications
The development of technologies for the efficient synthesis of innovative antiviral
compounds remains an important challenge for modern biotechnology, especially in the …
compounds remains an important challenge for modern biotechnology, especially in the …
HDX-MS reveals substrate-dependent, localized EX1 conformational dynamics in the retaining GT-B glycosyltransferase, MshA
R Karki, JT Hennek, W Chen, PA Frantom - Biochemistry, 2023 - ACS Publications
Glycosyltransferases (GTs) are well-characterized with respect to static 3D structures and
molecular dynamics simulations, but there is a lack of reports on in-solution dynamics on …
molecular dynamics simulations, but there is a lack of reports on in-solution dynamics on …
Evaluation of purine-nucleoside degrading ability and in vivo uric acid lowering of Streptococcus thermophilus IDCC 2201, a novel antiuricemia strain
D Kim, JS Moon, JE Kim, YJ Jang, HS Choi, I Oh - Plos one, 2024 - journals.plos.org
This study evaluated 15 lactic acid bacteria with a focus on their ability to degrade inosine
and hypo-xanthine—which are the intermediates in purine metabolism—for the …
and hypo-xanthine—which are the intermediates in purine metabolism—for the …
Kinetic and Structural Characterization of Trypanosoma cruzi Hypoxanthine–Guanine–Xanthine Phosphoribosyltransferases and Repurposing of Transition-State …
K Glockzin, KM Meneely, R Hughes, SW Maatouk… - Biochemistry, 2023 - ACS Publications
Over 70 million people are currently at risk of developing Chagas Disease (CD) infection,
with more than 8 million people already infected worldwide. Current treatments are limited …
with more than 8 million people already infected worldwide. Current treatments are limited …
Discovery of Novel Inhibitors of Cruzain Cysteine Protease of Trypanosoma cruzi
Chagas disease (CD) is a parasitic disease endemic in several developing countries.
According to the World Health Organization, approximately 6-8 million people worldwide are …
According to the World Health Organization, approximately 6-8 million people worldwide are …
Antiparasitic Activity of Oxindolimine–Metal Complexes against Chagas Disease
MC Portes, GA Ribeiro, GL Sabino, RAA De Couto… - Inorganics, 2023 - mdpi.com
Some copper (II) and zinc (II) complexes with oxindolimine ligands were tested regarding
their trypanocidal properties. These complexes have already shown good biological activity …
their trypanocidal properties. These complexes have already shown good biological activity …
Inhibition and Mechanism of Plasmodium falciparum Hypoxanthine–Guanine–Xanthine Phosphoribosyltransferase
Y VT Minnow, K Suthagar, K Clinch… - ACS chemical …, 2022 - ACS Publications
Plasmodium falciparum hypoxanthine–guanine–xanthine phosphoribosyltransferase (Pf
HGXPRT) is essential for purine salvage of hypoxanthine into parasite purine nucleotides …
HGXPRT) is essential for purine salvage of hypoxanthine into parasite purine nucleotides …
The design of protozoan phosphoribosyltransferase inhibitors containing non-charged phosphate mimic residues
Phosphate groups play essential roles in biological processes, including retention inside
biological membranes. Phosphodiesters link nucleic acids, and the reversible transfer of …
biological membranes. Phosphodiesters link nucleic acids, and the reversible transfer of …
寄生原虫嘌呤磷酸核糖转移酶研究进展.
余志会, 方肆云, 孙铭飞, 戚南山… - Guangdong …, 2023 - search.ebscohost.com
寄生原虫是一类单细胞寄生性原虫, 包括利什曼原虫(Leishmania spp.), 锥虫(Trypanosoma
spp.), 疟原虫(Plasmodium spp.), 刚地弓形虫(Toxoplasma gondii), 隐孢子虫(Cryptosporidium …
spp.), 疟原虫(Plasmodium spp.), 刚地弓形虫(Toxoplasma gondii), 隐孢子虫(Cryptosporidium …
Waltheriones and trypanosoma cruzi–elucidating potential mechanisms of action
S Beilstein - 2023 - edoc.unibas.ch
Natural products, and phytochemicals in particular, constitute a huge potential for drug
discovery and medical use against parasitic diseases. Novel drugs and safer and more …
discovery and medical use against parasitic diseases. Novel drugs and safer and more …